Heska Corp (HSKA.OQ)

HSKA.OQ on NASDAQ Stock Exchange Capital Market

6.90USD
12:00pm EDT
Price Change (% chg)

$-0.05 (-0.72%)
Prev Close
$6.95
Open
$6.85
Day's High
$6.90
Day's Low
$6.85
Volume
593
Avg. Vol
4,505
52-wk High
$10.22
52-wk Low
$6.60

HSKA.OQ

Chart for HSKA.OQ

About

Heska Corporation develops, manufactures, markets, sells and supports veterinary products. The Company is focused on the canine and feline companion animal health markets. It operates in two segments: Core Companion Animal Health and Other Vaccines, Pharmaceuticals and Products. The Core Companion Animal Health segment (CCA)... (more)

Overall

Beta: 1.63
Market Cap (Mil.): $40.05
Shares Outstanding (Mil.): 5.80
Dividend: 0.10
Yield (%): 5.80

Financials

  HSKA.OQ Industry Sector
P/E (TTM): 161.86 27.50 37.76
EPS (TTM): 0.04 -- --
ROI: 0.48 9.26 18.76
ROE: 0.48 12.54 19.59
Search Stocks

Competitors

  Price Change
Pfizer Inc. (PFE.N) $29.06 -0.17
Novartis AG (NOVN.VX) CHF66.60 +0.35
Merck & Co., Inc. (MRK.N) $48.20 +0.03
Bayer AG (BAYGn.DE) €89.43 +2.08
Bayer AG (BAYE.F) -- --
Sanofi SA (SASY.PA) €76.85 -3.32
Eli Lilly & Co. (LLY.N) $53.29 +0.18
IDEXX Laboratories, Inc. (IDXX.OQ) $99.52 +1.53
Virbac SA (VIRB.PA) €146.80 -3.20
Vetoquinol SA (VETO.PA) €26.68 -0.14

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Pechala's Reports
$15.00
Provider: Reuters Investment Profile
$20.00
Provider: Zacks Investment Research Inc.
$12.00
Provider: TheStreet.com Ratings
$10.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks